317
Participants
Start Date
August 17, 2022
Primary Completion Date
April 11, 2028
Study Completion Date
September 26, 2034
Linvoseltamab
Linvoseltamab is administered by intravenous (IV) infusion
Daratumumab
Daratumumab is administered by IV infusion and/or subcutaneous (SC) injection; SC injection may be used after a minimum of 2 cycles of IV administration at the investigator's discretion.
Carfilzomib
Carfilzomib is administered by IV infusion
Lenalidomide
Lenalidomide is administered by mouth (PO) as a capsule
Bortezomib
Bortezomib is administered by IV infusion or SC injection
Pomalidomide
Pomalidomide is administered by mouth (PO) as a capsule
Isatuximab
Isatuximab is administered by IV infusion
Fianlimab
Fianlimab is administered by IV infusion
Cemiplimab
Cemiplimab is administered by IV infusion
Nirogacestat
Nirogacestat is administered by mouth (PO) as a tablet
Cevostamab
Cevostamab is administered by IV infusion
RECRUITING
Weill Cornell Medicine/New York Presbyterian Hospital, New York
RECRUITING
New York Presbyterian Hospital Columbia University Medical Center, New York
RECRUITING
Evangelismos General Hospital, Athens
RECRUITING
General Hospital of Athens Alexandra, Athens
RECRUITING
Hospital Clinico Universitario de Santiago, Santiago de Compostela
RECRUITING
Wake Forest University Health Sciences, Winston-Salem
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Universitaru Hospital La Princesa, Madrid
RECRUITING
Clinica Universidad de Navarra - Madrid, Madrid
RECRUITING
Hospital Universitario Ramon y Cajal - Servicio de Psiquiatria, Madrid
RECRUITING
University Hospital and Research Institute, Madrid
RECRUITING
Hospital Universitario HM Sanchinarro, Madrid
RECRUITING
Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcón
RECRUITING
Winship Cancer Institute of Emory University, Atlanta
RECRUITING
Clinica Universidad de Navarra, Pamplona
RECRUITING
CHU Montpellier - Departement D'Hematologie, Montpellier
RECRUITING
University Hospital of Salamanca, Salamanca
RECRUITING
Hospital Universitario Marques de Valdecilla, Santander
RECRUITING
The Ohio State University James Cancer Hospital, Columbus
RECRUITING
Nantes University Hospital, Nantes
RECRUITING
Indiana University Health Simon Cancer Center, Indianapolis
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
Centre Hospitalier Universitaire Angers, Angers
RECRUITING
Mayo Clinic, Rochester
SUSPENDED
CHU de Lille - Rue Michel Polonovski, Lille
RECRUITING
Saint Louis Hospital, Paris
RECRUITING
Hopital Necker, Paris
RECRUITING
University of Texas Southwestern, Dallas
RECRUITING
Hopital Saint Antoine, Paris
RECRUITING
Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers
RECRUITING
Hadassah Medical Center, Jerusalem
RECRUITING
Scripps Clinic Torrey Pines, La Jolla
RECRUITING
Hospital Henri Mondor, Créteil
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
VA Puget Sound Health Care System, Seattle
RECRUITING
Rambam Health Care Campus, Haifa
RECRUITING
Sheba Medical Center, Ramat Gan
RECRUITING
Dana Farber/Harvard Cancer Center, Boston
RECRUITING
Hospital Germans Trias i Pujol, Badalona
RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
RECRUITING
Hospital Clinic de Barcelona, Barcelona
RECRUITING
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals,, Barcelona
Regeneron Pharmaceuticals
INDUSTRY